Aptevo Therapeutics Inc. Stock Split Ratio
Aptevo Therapeutics Inc. (APVO) had Stock Split Ratio of 6.00% as of 2025-12-29, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2026-08-14
- Aptevo Therapeutics Inc. stockholders' equity note, stock split, conversion ratio for the quarter ending 2025-06-30 was 2.00%.
- Aptevo Therapeutics Inc. stockholders' equity note, stock split, conversion ratio for the quarter ending 2024-03-31 was 2.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month as first filed |
|---|---|---|---|---|---|
| 2025-12-29 | 6.00% 10-K · filed 2026-03-26 | ||||
| 2025-12-17 | 6.00% 10-K · filed 2026-03-26 | ||||
| 2025-06-30 | 2.00% 10-Q · filed 2026-08-14 | 5.00% 10-Q · filed 2025-08-11 | |||
| 2025-05-23 | 5.00% 10-K · filed 2026-03-26 | ||||
| 2025-05-21 | 5.00% 10-K · filed 2026-03-26 | ||||
| 2024-12-03 | 3.00% 10-K · filed 2026-03-26 | ||||
| 2024-12-02 | 2.70% 10-Q · filed 2025-05-15 | 3.00% 10-K · filed 2025-02-14 | |||
| 2024-10-25 | 2.70% 10-Q · filed 2025-05-15 | 3.00% 10-K · filed 2025-02-14 | |||
| 2024-03-31 | 2.00% 10-Q · filed 2025-11-06 | ||||
| 2024-03-05 | 2.00% 10-K · filed 2026-03-26 | ||||
| 2024-03-04 | 2.00% 10-Q · filed 2025-05-15 | ||||
| 2024-02-27 | 2.00% 10-Q · filed 2025-05-15 | ||||
| 2020-03-26 | 7.10% 10-Q · filed 2021-11-12 | 7.10% 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |